Tag
The Schwannomatosis Open Research Collaborative (SORC) is an innovative, community-based research project aimed at utilizing publicly available data to uncover new scientific insights into the rare and understudied genet...
The Doris Duke Charitable Foundation is now accepting applications for the 2023 Physician Scientist Fellowship competition. Applications are due January 13, 2023, 3pm ET. Grants of $220,000 over two years ($100,000 direc...
The Neurofibromatosis Therapeutic Acceleration Program (NTAP) (www.n-tap.org) is a philanthropic research entity based at Johns Hopkins University School of Medicine dedicated to the discovery of therapeutics for the per...
The Gilbert Family Foundation’s (GFF) Gene Therapy Initiative is accepting proposals for high-impact research on gene therapy strategies aimed at addressing the loss of neurofibromin 1 (NF1) gene function in neurofibroma...
Applications are now open for the Children's Tumor Foundation's (CTF) 2021 cycle of Drug Discovery Initiative Registered Reports (DDIRR) award program, a program to fund early stage testing of candidate drug therapies fo...
In 1990, Dr. Francis S. Collins led the team that discovered the NF1 gene. Now it's your turn to join the team that discovers the cure. The Francis S. Collins Scholars Program in Neurofibromatosis Clinical & Translationa...
